乳腺肿瘤整形保乳手术联合颗粒型脱细胞真皮基质术后影像监测需要了解什么
回顾性分析105例乳腺肿瘤整形保乳联合脱细胞真皮基质(ADM)术后患者,随访乳腺X线摄影(MG)和超声(US)平均46.1个月。ADM在MG多表现为卵圆形、高密度伴钙化肿块,US多为卵圆形、边界清晰、不均匀回声伴声影。MG、US、MG+US监测敏感度分别为25%、50%、75%,特异度分别为100%、98%、98%。
要点
- ADM在MG上多呈卵圆形(94.3%)、高密度(53.3%)肿块伴钙化(51.4%),易与复发混淆。
- ADM在US上多呈卵圆形(88.6%)、边界清晰(66.7%)、不均匀回声(61.9%)伴声影(90.5%)。
- MG单用敏感度仅25%,MG+US联合敏感度75%,特异度98%。
核心结论
- 认识并充分解读ADM术后常规影像表现对监测至关重要;单用MG因ADM填充物密度不足以检出肿块型复发,MG+US联合可提高敏感度。
研究设计与样本
- 回顾性分析前瞻性收集数据库,105例接受肿瘤整形保乳联合ADM手术且术后2年以上有MG和US随访的患者,经IRB批准并符合HIPPA。
关键影像表现/征象
- MG上ADM表现为卵圆形(99/105,94.3%)、边界清晰或 obscured(65/105,61.9%)、高密度(56/105,53.3%)肿块,伴钙化(54/105,51.4%)。
- US上ADM填充腔表现为卵圆形(93/105,88.6%)、边界清晰(70/105,66.7%)、不均匀回声(65/105,61.9%)肿块,伴边缘或后方声影(95/105,90.5%)。
- 随访期间(平均46.1个月,范围26-58个月)诊断4例肿瘤复发(4/105,3.8%)。
- 1例复发在MG上表现为微钙化(1/4,25%),因形态和位置可疑而与良性术后钙化鉴别。
- 2例复发(2/4,50%)为MG阴性小肿块或导管内病变,由US检出。
诊断标准与关键数值
- MG术后监测敏感度25%、特异度100%。
- US术后监测敏感度50%、特异度98%。
- MG+US联合监测敏感度75%、特异度98%。
临床应用与阅片要点
- 应认识ADM术后在MG和US上的典型表现,避免误判为复发。
- 单用MG不足以检出肿块型复发,建议MG+US联合用于术后监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The aim of this study was to evaluate the usual postoperative imaging findings among patients who underwent oncoplastic breast-conserving surgery (BCS) with acellular dermal matrix (ADM) and to assess the clinical utility of mammography (MG) and ultrasonography (US) in follow-ups.
MATERIALS AND METHODS: This retrospective review of our prospectively collected database of patients who underwent oncoplastic BCS with ADM was conducted with IRB approval and in HIPPA compliance. A total of 105 patients whose follow-up MG and US studies over 2years after surgery were available were included in this study. Postoperative imaging findings were analyzed based on sequential MG and US follow-ups. The clinical outcomes and pathological data were also reviewed. The diagnostic performance of MG and US for postoperative surveillance was assessed.
RESULTS: On MG, ADM presented as an oval (99/105, 94.3%), circumscribed/obscured (65/105, 61.9%), and high-density (56/105, 53.3%) mass with calcifications (54/105, 51.4%). On US, the ADM-filled cavity presented as an oval (93/105, 88.6%), circumscribed (70/105, 66.7%), heterogenous echoic (65/105, 61.9%) mass with marginal/posterior acoustic shadowing (95/105, 90.5%) on US. During the follow-up period (mean, 46.1months; range, 26-58 months), four tumor recurrences were diagnosed (4/105, 3.8%). One tumor recurrence detected on MG presented as microcalcifications (1/4, 25%), which were differentiated from benign postoperative calcifications due to their suspicious morphology and location. Two additional recurrences (2/4, 50%), which were MG-negative small masses or intraductal lesions, were detected on US. One tumor recurrence was missed on both MG+US and was detected by magnetic resonance imaging performed at clinician's request. The sensitivity and specificity of MG, US, and MG+US for postoperative surveillance were 25%, 50% and 75% and 100%, 98% and 98%, respectively.
CONCLUSION: Recognition and adequate interpretation of the usual findings after oncoplastic BCS with ADM insertion are important in postoperative imaging surveillance. The sole use of MG is not sufficient for the detection of mass-type tumor recurrence due to the density of inserted ADM fillers. Therefore, the combined use of MG+US could serve as a useful postoperative surveillance tool with increased sensitivity in this population.
引用
- An, Hwang, Suh, et al. What Should We Know in Postoperative Surveillance Imaging After Oncoplastic Breast-Conserving Surgery with Pellet-Type Acellular Dermal Matrix? Acad Radiol. 2023. PMID: 37263859. doi:10.1016/j.acra.2023.04.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。